Mirae Asset Global Investments Co. Ltd. Purchases 67,835 Shares of Cardinal Health, Inc. $CAH

Posted by Geri Gentry on Nov 4th, 2026

Mirae Asset Global Investments Co. Ltd. bought a new stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 67,835 shares of the company’s stock, valued at approximately $15,093,000.

Several other hedge funds have also added to or reduced their stakes in CAH. Vise Technologies Inc. lifted its stake in shares of Cardinal Health by 22.3% during the 3rd quarter. Vise Technologies Inc. now owns 11,641 shares of the company’s stock worth $2,590,000 after buying an additional 2,121 shares during the last quarter. Investment Partners LTD. boosted its stake in shares of Cardinal Health by 69.4% in the third quarter. Investment Partners LTD. now owns 1,628 shares of the company’s stock valued at $362,000 after buying an additional 667 shares during the period. MGO One Seven LLC grew its holdings in shares of Cardinal Health by 5.9% during the 3rd quarter. MGO One Seven LLC now owns 10,156 shares of the company’s stock worth $2,260,000 after purchasing an additional 569 shares in the last quarter. Modera Wealth Management LLC grew its stake in Cardinal Health by 92.1% during the third quarter. Modera Wealth Management LLC now owns 2,203 shares of the company’s stock worth $490,000 after buying an additional 1,056 shares in the last quarter. Finally, Raleigh Capital Management Inc. boosted its position in shares of Cardinal Health by 2.9% during the 3rd quarter. Raleigh Capital Management Inc. now owns 1,541 shares of the company’s stock worth $343,000 after acquiring an additional 43 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Buying and Selling

In related news, insider Jessica Mayer sold 29,436 shares of the business’s stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $236.19, for a total value of $6,952,488.84. Following the sale, the insider owned 33,076 shares of the company’s stock, valued at $7,812,220.44. The trade was a 47.09% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Deborah Weitzman sold 7,354 shares of the stock in a transaction on Tuesday, August 18th. The shares were sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the sale, the chief executive officer owned 77,901 shares of the company’s stock, valued at $18,341,790.45. The trade was a 8.63% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 210,271 shares of company stock valued at $49,626,657 over the last quarter. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Price Performance

Shares of NYSE CAH opened at $253.32 on Wednesday. The company has a 50 day simple moving average of $238.67 and a 200 day simple moving average of $222.72. Cardinal Health, Inc. has a 1 year low of $180.45 and a 1 year high of $259.84. The firm has a market cap of $58.66 billion, a PE ratio of 35.04, a price-to-earnings-growth ratio of 1.53 and a beta of 0.53.

Cardinal Health (NYSE:CAH – Get Free Report) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same period in the previous year, the firm posted $2.08 EPS. The company’s revenue for the quarter was up 5.8% compared to the same quarter last year. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. As a group, research analysts anticipate that Cardinal Health, Inc. will post 12.55 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st were issued a dividend of $0.5158 per share. This represents a $2.06 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date was Thursday, October 1st. Cardinal Health’s payout ratio is 28.49%.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the company. JPMorgan Chase & Co. lifted their target price on Cardinal Health from $215.00 to $260.00 and gave the company a “neutral” rating in a research report on Thursday, August 13th. Wells Fargo & Company increased their price target on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research note on Wednesday, August 12th. Barclays raised their price objective on Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, August 13th. Morgan Stanley boosted their price objective on Cardinal Health from $265.00 to $286.00 and gave the stock an “overweight” rating in a research report on Friday, October 30th. Finally, Robert W. Baird upped their target price on Cardinal Health from $251.00 to $274.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $270.69.

Get Our Latest Analysis on Cardinal Health

Cardinal Health Company Profile

(Free Report)

Cardinal Health, Inc is a healthcare services and products company that supports the distribution and delivery of pharmaceuticals, medical products and related services. The company serves hospitals, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, as well as consumer health products, to pharmacies and healthcare institutions.